Related Experiment Video
Updated: Jun 2, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
Ras/Raf/MEK/ERK pathway is associated with lung metastasis of osteosarcoma in an orthotopic mouse model
Yan Yu1, Frederick Luk, Jia-Lin Yang
1Prince of Wales Clinical School, University of New South Wales, Randwick, NSW 2031, Australia. y.yu@unsw.edu.au
Aim:
To identify a marker of osteosarcoma metastasis and to inhibit the marker against the invasive ability of an osteosarcoma cell line (143B).
Materials And Methods:
Type I insulin-like growth factor receptor (IGF-1R) and its downstream signalling factors were measured in samples from our orthotopic 143B mouse model by immunohistochemistry. A Matrigel assay was used to assess cell invasion ability under interference.
Results:
All 15 mice had tumour mass at the left tibia. Total IGF-1R, MEK, Akt, p38 and phosphorylated MEK (p-MEK), but not p-Akt and p-p38, were positive in both local tumours and lung secondaries. Leiomyosarcoma controls expressed p-Akt and p-MEK, but not p-p38. The 143B cells treated with U0126, a MEK/ERK inhibitor, had significantly lower in vitro invasion ability compared with controls.
Conclusion:
The IGF-1R-MEK signalling pathway, particularly Ras/Raf/MEK/ERK, may play an important role in osteosarcoma lung metastasis, and the targeting MEK/ERK by its specific inhibitor may have a potential use in the effective treatment of osteosarcoma.
More Related Videos
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
Related Concept Videos
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway